Navigation Links
Stem Cell Marker Controls Pair of Key Cancer Pathways
Date:4/14/2008

Work suggests, but does not prove, that stem cells drive breast cancer formation, researcher says

MONDAY, April 14 (HealthDay News) -- New findings by researchers suggest breast cancer may arise from stem cells and that targeting a certain gene linked to these cells may be a key to treatment.

Researchers from Georgetown University Medical Center report that the Musashi1 (Msi1) gene can flip open two known cancer pathways in mammary cells. The gene had been shown in previous studies to be a stem cell marker in several parts of the body.

The findings were expected to be presented April 14 at the annual meeting of the American Association for Cancer Research (AACR) in San Diego.

"This is the first time any role has been attributed to this gene, and it turns out to be one that is surprisingly powerful," study lead author, Xiaoyang Wang, a postdoctoral fellow at Georgetown's Lombardi Comprehensive Cancer Center, said in a prepared statement.

The study, done in a laboratory setting, shows the Msi1 gene regulates cell signaling in two mammary cells pathways -- Wnt and Notch. Both pathways help regulate stem cell growth, and past studies have tabbed them as critical players in the development of many cancers.

The researchers work also uncovered that Msi1 is expressed in particularly aggressive tumors. This finding fuels a debate among cancer researchers following recent studies indicating stem cells may be the root cause of some cancers.

"It is really critical to understand if stem cells are involved in cancer development, because a lot of therapies used to treat cancer don't target stem cells," study senior author Robert Glazer, a Georgetown professor of oncology and pharmacology, said in a prepared statement. "That may explain why tumors come back."

Wang concluded: "This work suggests, but does not prove, that stem cells drive breast cancer formation. Msi1 might make a good therapeutic target, and we are currently testing ways to interfere with its function in cells to see if it disrupts cancer cell proliferation."

More information

The U.S. National Cancer Institute has more about breast cancer.



-- Kevin McKeever



SOURCE: Georgetown University, news release, April 14, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. UCLA researchers identify markers that may predict diabetes in still-healthy people
2. First biomarker discovered that predicts prostate cancer outcome
3. Penn School of Medicine receives $2.3 million to study biomarkers of cigarette smoke exposure
4. Liver cancer marker could yield blood test for early detection
5. Blood Marker Might Help Spot Early Liver Cancer
6. Radiologists identify early brain marker of Alzheimers disease
7. Study makes progress in zoning in on biomarkers for better colon cancer treatment
8. New Ovarian Cancer Biomarker Research Act Introduced
9. Study shows blood markers can help choose best dose for antiangiogenic drugs
10. Mayo Clinic study points to a possible biomarker for colon cancer in people 50 and under
11. Singulex Announces Presentation on Monitoring of Cardiac Biomarker to Assess Transient Myocardial Ischemia at the American Heart Association Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... Flottman Company is ... As a means of expanding capabilities Flottman has added a G&K Vijuk ... code professional inserts (PIs) and patient package inserts (PPIs) that will marry with ...
(Date:12/9/2016)... ... 2016 , ... Mediaplanet today announces distribution of the latest edition of “Transplants,” ... up as an organ donor for the 123,000 people in the United States who ... save up to 8 saves through organ donation and enhance many others through tissue ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical ... 2017. The name change aligns the entire company with its existing Quality ... quality. , “We are very proud of the achievements associated with the West ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest Healthcare ... owned by an affiliate of Seavest, has won a prestigious national healthcare real ... County ambulatory care center (ACC) was named “Best New Development, MOBs and Other ...
(Date:12/8/2016)... ... ... Premier Fitness Camp (PFC) and The Chopra Center for Wellbeing announced today the launch ... world headquarters of Omni La Costa Resort & Spa in San Diego. , Chopra ... personal development, a healthy lifestyle, or mental and physical healing. The week-long wellness program ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)...  Eli Lilly and Company (NYSE: LLY ... EXPEDITION3 trial at the 9 th Clinical Trials ... did not meet the primary endpoint in the EXPEDITION3 ... with mild dementia due to Alzheimer,s disease (AD), and ... the treatment of mild dementia due to AD. ...
(Date:12/8/2016)... QUEBEC CITY , Dec. 8, 2016 /PRNewswire/ ... key US patents for improving the accuracy, reproducibility ... CD images in long and small bone orthopaedic ... proprietary approach to creating personalized orthopaedic restorations based ... create personalized orthopaedic restorations, the company harnesses the ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, ... has obtained proof-of-mechanism for neflamapimod (previously code named ... Phase 2a clinical trials that demonstrated significant Alzheimer,s ... 302 (12-week treatment) and Study 303 (6-week treatment) ... Trials in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: